RWDD1 antibody
Principal name
RWDD1 antibody
Alternative names for RWDD1 antibody
DFRP2, RWD domain-containing protein 1, DRG family-regulatory protein 2
Ncbi ID
9606, NP_057036, NP_057036.2, NM_016104, NM_001007464, NP_001007465, NP_079890.1, NM_147146, NM_015952
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of RWDD1 antibody
- Kit Component:
- - KN315216G1, Rwdd1 gRNA vector 1 in pCas-Guide vector
- KN315216G2, Rwdd1 gRNA vector 2 in pCas-Guide vector
- KN315216D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Kang N, et al. (2008) Cell Mol Immunol. 5(5):333-9.Grötsch H, et al. (2012) Mol Cell Endocrinol. 358(1):53-62.
Western Blot analysis of RWDD1 expression in transfected 293T cell line (H00051389-T02) by RWDD1 MaxPab polyclonal antibody.Lane 1: RWDD1 transfected lysate(26.73 KDa).Lane 2: Non-transfected lysate.
Human HeLa; WB Suggested Anti-RWDD1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Hela cell lysate. RWDD1 is supported by BioGPS gene expression data to be expressed in HeLa.; RWDD1 antibody - middle region (ARP56838_P050) in Human HeLa cells using Western Blot
Human Jurkat; WB Suggested Anti-RWDD1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Jurkat cell lysate. RWDD1 is supported by BioGPS gene expression data to be expressed in Jurkat.; RWDD1 antibody - middle region (ARP59212_P050) in Human Jurkat cells using Western Blot
WB Suggested Anti-RWDD1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Hela cell lysateRWDD1 is supported by BioGPS gene expression data to be expressed in HeLa
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP321813 | RWDD1 (transcript variant 3) |
||||
| Recombinant protein of human RWD domain containing 1 (RWDD1), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY414180 | RWDD1 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY423486 | RWDD1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC221813L1V | Lenti ORF particles, RWDD1 (Myc-DDK tagged) - Human RWD domain containing 1 (RWDD1), transcript variant 3 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR201218L2V | Lenti ORF particles, Rwdd1 (GFP-tagged ORF) - Rat RWD domain containing 1 (Rwdd1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR201218L1V | Lenti ORF particles, Rwdd1 (Myc-DDK-tagged ORF) - Rat RWD domain containing 1 (Rwdd1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
